| Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial L Hansson, A Zanchetti, SG Carruthers, B Dahlöf, D Elmfeldt, S Julius, ... The Lancet 351 (9118), 1755-1762, 1998 | 9104 | 1998 |
| Clearance systems in the brain—implications for Alzheimer disease JM Tarasoff-Conway, RO Carare, RS Osorio, L Glodzik, T Butler, ... Nature reviews neurology 11 (8), 457-470, 2015 | 1593 | 2015 |
| Cardiovascular prognosis of masked hypertension detected by blood pressure self-measurement in elderly treated hypertensive patients G Bobrie, G Chatellier, N Genes, P Clerson, L Vaur, B Vaisse, J Menard, ... Jama 291 (11), 1342-1349, 2004 | 1196 | 2004 |
| Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I J MENARD, KJ Catt Endocrinology 90 (2), 422-430, 1972 | 524 | 1972 |
| Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. M Marre, G Chatellier, H Leblanc, TT Guyene, J Menard, P Passa British Medical Journal 297 (6656), 1092-1095, 1988 | 515 | 1988 |
| Masked hypertension: a systematic review G Bobrie, P Clerson, J Ménard, N Postel-Vinay, G Chatellier, PF Plouin Journal of hypertension 26 (9), 1715-1725, 2008 | 461 | 2008 |
| Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. M Azizi, A Rousseau, E Ezan, TT Guyene, S Michelet, JM Grognet, ... The Journal of clinical investigation 97 (3), 839-844, 1996 | 423 | 1996 |
| Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo … M Marre, M Lievre, G Chatellier, JFE Mann, P Passa, J Ménard Bmj 328 (7438), 495, 2004 | 380 | 2004 |
| Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. M Marre, H Leblanc, L Suarez, TT Guyenne, J Menard, P Passa Br Med J (Clin Res Ed) 294 (6585), 1448-1452, 1987 | 363 | 1987 |
| Efficacy and tolerance of spironolactone in essential hypertension X Jeunemaitre, G Chatellier, C Kreft-Jais, A Charru, C Devries, PF Plouin, ... The American journal of cardiology 60 (10), 820-825, 1987 | 358 | 1987 |
| Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up E Abergel, G Chatellier, AA Hagege, A Oblak, A Linhart, A Ducardonnet, ... Journal of the American College of Cardiology 44 (1), 144-149, 2004 | 352 | 2004 |
| A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism HK Parthasarathy, J Ménard, WB White, WF Young Jr, GH Williams, ... Journal of hypertension 29 (5), 980-990, 2011 | 323 | 2011 |
| Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II–renin … M Azizi, J Menard, A Bissery, TT Guyenne, A Bura-Riviere, ... Journal of the American Society of Nephrology 15 (12), 3126-3133, 2004 | 316 | 2004 |
| The number needed to treat: a clinically useful nomogram in its proper context G Chatellier, E Zapletal, D Lemaitre, J Menard, P Degoulet Bmj 312 (7028), 426-429, 1996 | 298 | 1996 |
| Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives M Azizi, G Chatellier, TT Guyene, D Murieta-Geoffroy, J Ménard Circulation 92 (4), 825-834, 1995 | 293 | 1995 |
| Antiandrogenic effect of spirolactones: mechanism of action P Corvol, A MICHAUD, J MENARD, M FREIFELD, J MAHOUDEAU Endocrinology 97 (1), 52-58, 1975 | 291 | 1975 |
| Determinants of angiotensin II generation during converting enzyme inhibition. L Juillerat, J Nussberger, J Menard, V Mooser, Y Christen, B Waeber, ... Hypertension 16 (5), 564-572, 1990 | 277 | 1990 |
| Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists M Azizi, J Ménard Circulation 109 (21), 2492-2499, 2004 | 256 | 2004 |
| A micromethod for measurement of renin in the plasma and kidney of rats R Boucher, J Menard, J Genest Canadian Journal of Physiology and Pharmacology 45 (5), 881-890, 1967 | 249 | 1967 |
| Which definition for echocardiographic left ventricular hypertrophy? E Abergel, M Tase, J Bohlender, G Chatellier The American journal of cardiology 75 (7), 498-502, 1995 | 244 | 1995 |
